DWT
UTHR icon

Dorsey & Whitney Trust’s United Therapeutics UTHR Stock Holding History

Dorsey & Whitney Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Sell
423
-12
-3% -$6.76K 0.01% 681
2026
Q1 		$258K Sell
435
-1
-0.2% -$498 0.01% 615
2025
Q4 		$212K Buy
+436
New +$203K 0.01% 666

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Dorsey & Whitney Trust's UTHR Position: Q2 2026 in Review

Dorsey & Whitney Trust reduced its United Therapeutics (UTHR) stake by 2.8% in Q2 2026, selling an estimated $6.76K and leaving 423 shares worth $229K. The position accounts for 0.01% of the portfolio, ranked #681.

Dorsey & Whitney Trust first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $258K in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Dorsey & Whitney Trust held 423 shares of United Therapeutics worth $229K as of Q2 2026.
  • Dorsey & Whitney Trust sold 12 United Therapeutics shares in Q2 2026, an estimated $6.76K.
  • United Therapeutics made up 0.01% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #681 holding.
  • Dorsey & Whitney Trust first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Dorsey & Whitney Trust's United Therapeutics position peaked at $258K in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.